Sagimet Biosciences to host virtual KOL event Sept. 30
Sagimet Biosciences said it will host a virtual KOL event on Sept. 30, 2026, on denifanstat update data and a planned AURORA Phase 3 clinical trial in the US.
Sagimet Biosciences said it will host a virtual KOL event on Sept. 30, 2026, on denifanstat update data and a planned AURORA Phase 3 clinical trial in the US.